Mast cell exocytosis in airway inflammation

Therapeutic Targets in Airway Inflammation

Volumn , Issue , 2003, Pages 327-348

  Adachi, Roberto ^a   Dickey, Burton F ^a   Nigam, Rupesh ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67749117663     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (182)

1. Hart PH. Regulation of the inflammatory response in asthma by mast cell products.Immunol Cell Biol 2001; 79:149-153.
2. Busse WW, Lemanske RF, Jr. Asthma. N Engl J Med 2001; 344:350-362.
3. Page S, Ammit AJ, Black JL, Armour CL. Human mast cell and airway smooth musclecell interactions: Implications for asthma. Am J Physiol Lung Cell Mol Physiol 2001;281:L1313-L1323.
4. Bingham CO, Austen KF. Mast-cell responses in the development of asthma. J AllergyClin Immunol 2000; 105:S527-S534.
5. Malaviya R, Abraham SN. Mast cell modulation of immune responses to bacteria.Immunol Rev 2001; 179:16-24.
6. Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC. Impaired mast cell-dependentnatural immunity in complement C3-deficient mice. Nature 1997; 390:172-175.
7. Malaviya R, Ross E, Jakschik BA, Abraham SN. Mast cell degranulation induced bytype 1 fimbriated Escherichia coli in mice. J Clin Invest 1994; 93:1645-1653.
8. Abraham SN, Malaviya R. Mast cell modulation of the innate immune response toenterobacterial infection. Adv Exp Med Biol 2000; 479:91-105.
9. Sutton BJ, Gould HJ. The human IgE network. Nature 1993; 366:421-428.
10. Abraham SN, Malaviya R. Mast cells in infection and immunity. Infect Immun 1997;65:3501-3508.
11. Milgrom H, Fick RB, Jr, Su JQ, Reimann JD, Bush RK, Watrous ML, Metzger WJ.Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 1999;341:1966-1973.
12. Malaviya R, Ross EA, MacGregor JI, Ikeda T, Little JR, Jakschik BA, AbrahamSN. Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol 1994; 152:1907-1914.
13. Arock M, Ross E, Lai-Kuen R, Averlant G, Gao Z, Abraham SN. Phagocytic andtumor necrosis factor alpha response of human mast cells following exposure to gramnegative and gram-positive bacteria. Infect Immun 1998; 66:6030-6034.
14. Poncet P, Arock M, David B. MHC class II-dependent activation of CD4+ T cellhybridomas by human mast cells through superantigen presentation. J Leukoc Biol1999; 66:105-112.
15. Frandji P, Oskeritzian C, Cacaraci F, Lapeyre J, Peronet R, David B, Guillet JG, Mecheri S. Antigen-dependent stimulation by bone marrow-derived mast cells of MHCclass II-restricted T cell hybridoma. J Immunol 1993; 151:6318-6328.
16. Fernandez JM, Neher E, Gomperts BD. Capacitance measurement reveals stepwisefusion events in degranulating mast cells. Nature 1984; 312:453-455.
17. Lawson D, Raff MC, Gomperts B, Fewtrell C, Gilula NB. Molecular events duringmembrane fusion. A study of exocytosis in rat peritoneal mast cells. J Cell Biol 1977;72:242-259.
18. Peters SP, MacGlashan DW, Jr, Schulman ES, Schleimer RP, Hayes EC, Rokach J, Adkinson NF, Jr, Lichtenstein LM. Arachidonic acid metabolism in purified humanlung mast cells. J Immunol 1984; 132:1972-1979.
19. Schleimer RP, Davidson DA, Lichtenstein LM, Adkinson NF, Jr. Selective inhibitionof arachidonic acid metabolite release from human lung tissue by antiinflammatorysteroids. J Immunol 1986; 136:3006-3011.
20. Kobayashi H, Ishizuka T, Okayama Y. Human mast cells and basophils as sources ofcytokines. Clin Exp Allergy 2000; 30:1205-1212.
21. Lam BK, Xu K, Atkins MB, Austen KF. Leukotriene C4 uses a probenecid-sensitiveexport carrier that does not recognize leukotriene B4. Proc Natl Acad Sci USA 1992;89:11598-11602.
22. Bartosz G, Konig J, Keppler D, Hagmann W. Human mast cells secreting leukotrieneC4 express the MRP1 gene-encoded conjugate export pump. Biol Chem 1998; 379:1121-1126.
23. Leier I, Jedlitschky G, Buchholz U, Keppler D. Characterization of the ATP-dependentleukotriene C4 export carrier in mastocytoma cells. Eur J Biochem 1994; 220:599-606.
24. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ. ProstaglandinD2 generation after activation of rat and human mast cells with anti-IgE. J Immunol1982; 129:1627-1631.
25. Lewis RA, Holgate ST, Roberts LJ, Oates JA, Austen KF. Preferential generation ofprostaglandin D2 by rat and human mast cells. Kroc Found Ser 1981; 14:239-254.
26. Razin E, Mencia-Huerta JM, Stevens RL, Lewis RA, Liu FT, Corey E, Austen KF.IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. JExp Med 1983; 157:189-201.
27. Razin E, Mencia-Huerta JM, Lewis RA, Corey EJ, Austen KF. Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow.Proc Natl Acad Sci USA 1982; 79:4665-4667.
28. Heavey DJ, Ernst PB, Stevens RL, Befus AD, Bienenstock J, Austen KF. Generationof leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activatedrat intestinal mucosa mast cells. J Immunol 1988; 140:1953-1957.
29. Ghaffar O, Laberge S, Jacobson MR, Lowhagen O, Rak S, Durham SR, Hamid Q.IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: Comparison with IL-4 expression and modulation by topical glucocorticoid therapy. Am J Respir Cell MolBiol 1997; 17:17-24.
30. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, HeusserCH, Howarth PH, Holgate ST. Interleukin-4, -5, and -6 and tumor necrosis factor-ain normal and asthmatic airways: Evidence for the human mast cell as a source ofthese cytokines. Am J Respir Cell Mol Biol 1994; 10:471-480.
31. Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH.Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhiniticsubjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosalinflammation. J Immunol 1993; 151:3853-3865.
32. Razin E, Leslie KB, Schrader JW. Connective tissue mast cells in contact with fibroblasts express IL-3 mRNA. Analysis of single cells by polymerase chain reaction. JImmunol 1991; 146:981-987.
33. Okayama Y, Petit-Frere C, Kassel O, Semper A, Quint D, Tunon-de-Lara MJ, Bradding P, Holgate ST, Church MK. IgE-dependent expression of mRNA for IL-4 and IL-5in human lung mast cells. J Immunol 1995; 155:1796-1808.
34. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennialallergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, andIL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997; 99:1492-1499.
35. Bressler RB, Lesko J, Jones ML, Wasserman M, Dickason RR, Huston MM, CookSW, Huston DP. Production of IL-5 and granulocyte-macrophage colony-stimulatingfactor by naive human mast cells activated by high-affinity IgE receptor ligation. JAllergy Clin Immunol 1997; 99:508-514.
36. Gagari E, Tsai M, Lantz CS, Fox LG, Galli SJ. Differential release of mast cell interleukin-6 via c-kit. Blood 1997; 89:2654-2663.
37. Hultner L, Szots H, Welle M, Van Snick J, Moeller J, Dormer P. Mouse bone marrow-derived IL-3-dependentmast cells and autonomous sublines produce IL-6. Immunology1989; 67:408-413.
38. Gomi K, Zhu FG, Marshall JS. Prostaglandin E2 selectively enhances the IgE-mediatedproduction of IL-6 and granulocyte-macrophage colony-stimulating factor by mastcells through an EP1/EP3-dependent mechanism. J Immunol 2000; 165:6545-6552.
39. Stassen M, Arnold M, Hultner L, Muller C, Neudorfl C, Reineke T, Schmitt E. Murinebone marrow-derived mast cells as potent producers of IL-9: Costimulatory functionof IL-10 and kit ligand in the presence of IL-1. J Immunol 2000; 164:5549-5555.
40. Toru H, Pawankar R, Ra C, Yata J, Nakahata T. Human mast cells produce IL-13 byhigh-affinity IgE receptor cross-linking: Enhanced IL-13 production by IL-4-primedhuman mast cells. J Allergy Clin Immunol 1998; 102:491-502.
41. Kobayashi H, Okayama Y, Ishizuka T, Pawankar R, Ra C, Mori M. Production of IL-13 by human lung mast cells in response to Fcepsilon receptor cross-linkage. Clin ExpAllergy 1998; 28:1219-1227.
42. +T lymphocyte chemoattractant factor, IL-16. J Immunol 1997; 159:2904-2910.
43. Williams CM, Coleman JW. Induced expression of mRNA for IL-5, IL-6, TNF-alpha, MIP-2 and IFN-gamma in immunologically activated rat peritoneal mast cells: Inhibition by dexamethasone and cyclosporin A. Immunology 1995; 86:244-249.
44. Csonga R, Prieschl EE, Jaksche D, Novotny V, Baumruker T. Common and distinctsignaling pathways mediate the induction of TNF-alpha and IL-5 in IgE plus antigen-stimulated mast cells. J Immunol 1998; 160:273-283.
45. Gupta AA, Leal-Berumen I, Croitoru K, Marshall JS. Rat peritoneal mast cells produceIFN-gamma following IL-12 treatment but not in response to IgE-mediated activation.J Immunol 1996; 157:2123-2128.
46. Moller A, Henz BM, Grutzkau A, Lippert U, Aragane Y, Schwarz T, Kruger-Krasa-gakes S. Comparative cytokine gene expression: Regulation and release by human mastcells. Immunology 1998; 93:289-295.
47. Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mastcells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growthfactor beta and tumor necrosis factor alpha. J Exp Med 1994; 180:2027-2037.
48. Lin TJ, Issekutz TB, Marshall JS. Human mast cells transmigrate through humanumbilical vein endothelial monolayers and selectively produce IL-8 in response tostromal cell-derived factor-1alpha. J Immunol 2000; 165:211-220.
49. Moller A, Lippert U, Lessmann D, Kolde G, Hamann K, Welker P, Schadendorf D, Rosenbach T, Luger T, Czarnetzki BM. Human mast cells produce IL-8. J Immunol1993; 151:3261-3266.
50. Wakahara S, Fujii Y, Nakao T, Tsuritani K, Hara T, Saito H, Ra C. Gene expressionprofiles for FcepsilonRI, cytokines and chemokines upon FcepsilonRI activation inhuman cultured mast cells derived from peripheral blood. Cytokine 2001; 16:143-152.
51. Zhu FG, Gomi K, Marshall JS. Short-term and long-term cytokine release by mousebone marrow mast cells and the differentiated KU-812 cell line are inhibited by brefel-din A. J Immunol 1998; 161:2541-2551.
52. Marquardt DL, Alongi JL, Walker LL. The phosphatidylinositol 3-kinase inhibitorwortmannin blocks mast cell exocytosis but not IL-6 production. J Immunol 1996;156:1942-1945.
53. Henkel G, Brown MA. PU.1 and GATA: Components of a mast cell-specific interleukin4 intronic enhancer. Proc Natl Acad Sci USA 1994; 91:7737-7741.
54. Baumgartner RA, Yamada K, Deramo VA, Beaven MA. Secretion of TNF from a ratmast cell line is a Brefeldin A-sensitive and a calcium/protein kinase C-regulatedprocess. J Immunol 1994; 153:2609-2614.
55. Hural JA, Kwan M, Henkel G, Hock MB, Brown MA. An intron transcriptional enhancer element regulates IL-4 gene locus accessibility in mast cells. J Immunol 2000;165:3239-3249.
56. Sherman MA, Secor VH, Lee SK, Lopez RD, Brown MA. STAT6-independent production of IL-4 by mast cells. Eur J Immunol 1999; 29:1235-1242.
57. Sherman MA, Nachman TY, Brown MA. Cutting edge: Il-4 production by mast cellsdoes not require c-maf. J Immunol 1999; 163:1733-1736.
58. Beil WJ, Login GR, Galli SJ, Dvorak AM. Ultrastructural immunogold localizationof tumor necrosis factor-a to the cytoplasmic granules of rat peritoneal mast cells withrapid microwave fixation. J Allergy Clin Immunol 1994; 94:531-536.
59. Bacci S, Rucci L, Riccardi-Arbi R, Borghi-Cirri MB. Colocalization of tumor necrosisfactor-alpha and nitric oxide-synthase immunoreactivity in mast cell granules of nasalmucosa. Histol Histopathol 1998; 13:1011-1014.
60. Wilson SJ, Shute JK, Holgate ST, Howarth PH, Bradding P. Localization of interleukin(IL)-4 but not IL-5 to human mast cell secretory granules by immunoelectron microscopy. Clin Exp Allergy 2000; 30:493-500.
61. Dragonetti A, Baldassarre M, Castino R, Demoz M, Luini A, Buccione R, Isidoro C.The lysosomal protease cathepsin D is efficiently sorted to and secreted from regulatedsecretory compartments in the rat basophilic/mast cell line RBL. J Cell Sci 2000;113(Pt 18):3289-3298.
62. Turner H, Kinet JP. Signalling through the high-affinity IgE receptor Fc epsilonRI.Nature 1999; 402:B24-B30.
63. Leal-Berumen I, Conlon P, Marshall JS. IL-6 production by rat peritoneal mast cellsis not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol 1994; 152:5468-5476.
64. Wedemeyer J, Tsai M, Galli SJ. Roles of mast cells and basophils in innate and acquiredimmunity. Curr Opin Immunol 2000; 12:624-631.
65. Oku Y, Itayama H, Kamiya M. Expulsion of Trichinella spiralis from the intestine ofW/Wv mice reconstituted with haematopoietic and lymphopoietic cells and origin ofmucosal mast cells. Immunology 1984; 53:337-344.
66. Knight PA, Wright SH, Lawrence CE, Paterson YY, Miller HR. Delayed expulsionof the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specificgranule chymase, mouse mast cell protease-1. J Exp Med 2000; 192:1849-1856.
67. Galli SJ, Wershil BK. The two faces of the mast cell. Nature 1996; 381:21-22.
68. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a modelof acute septic peritonitis. Nature 1996; 381:75-77.
69. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influxand bacterial clearance at sites of infection through TNF-alpha. Nature 1996; 381:77-80.
70. Gommerman JL, Oh DY, Zhou X, Tedder TF, Maurer M, Galli SJ, Carroll MC. Arole for CD21/CD35 and CD19 in responses to acute septic peritonitis: A potentialmechanism for mast cell activation. J Immunol 2000; 165:6915-6921.
71. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles ofmast cells against enterobacterial infection are mediated by Toll-like receptor 4. JImmunol 2001; 167:2250-2256.
72. Malaviya R, Abraham SN. Role of mast cell leukotrienes in neutrophil recruitmentand bacterial clearance in infectious peritonitis. J Leukoc Biol 2000; 67:841-846.
73. Maurer M, Echtenacher B, Hultner L, Kollias G, Mannel DN, Langley KE, Galli SJ.The c-kit ligand, stem cell factor, can enhance innate immunity through effects onmast cells. J Exp Med 1998; 188:2343-2348.
74. Galli SJ. New concepts about the mast cell. N Engl J Med 1993; 328:257-265.
75. Curry JJ. The action of histamine on the respiratory tract in normal and asthmaticsubjects. J Clin Invest 1946; 25:785-791.
76. Casale TB, Wood D, Richerson HB, Trapp S, Metzger WJ, Zavala D, Hunning-hake GW. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmaticsare associated with methacholine bronchial hyperresponsiveness. J Clin Invest 1987;79:1197-1203.
77. Rankin JA, Kaliner M, Reynolds HY. Histamine levels in bronchoalveolar lavage frompatients with asthma, sarcoidosis, and idiopathic pulmonary fibrosis. J Allergy ClinImmunol 1987; 79:371-377.
78. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun2000; 279:615-620.
79. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes.J Biol Chem 2000; 275:36781-36786.
80. Arrang JM, Drutel G, Garbarg M, Ruat M, Traiffort E, Schwartz JC. Molecular andfunctional diversity of histamine receptor subtypes. Ann NY Acad Sci 1995; 757:314-323.
81. Marthan R, Crevel H, Guenard H, Savineau JP. Responsiveness to histamine in humansensitized airway smooth muscle. Respir Physiol 1992; 90:239-250.
82. Knight DA, Stewart GA, Thompson PJ. Prostaglandin E2, but not prostacyclin inhibitshistamine-induced contraction of human bronchial smooth muscle. Eur J Pharmacol1995; 272:13-19.
83. Ellis JL, Undem BJ. Role of cysteinyl-leukotrienes and histamine in mediating intrinsictone in isolated human bronchi. Am J Respir Crit Care Med 1994; 149:118-122.
84. Johnson PR, Ammit AJ, Carlin SM, Armour CL, Caughey GH, Black JL. Mast celltryptase potentiates histamine-induced contraction in human sensitized bronchus. EurRespir J 1997; 10:38-43.
85. Panettieri RA, Yadvish PA, Kelly AM, Rubinstein NA, Kotlikoff MI. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am J Physiol1990; 259:L365-L371.
86. Webber SE, Salonen RO, Widdicombe JG. H1- and H2-receptor characterization inthe tracheal circulation of sheep. Br J Pharmacol 1988; 95:551-561.
87. Evans TW, Rogers DF, Aursudkij B, Chung KF, Barnes PJ. Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in theguinea pig. Clin Sci (Lond) 1989; 76:479-485.
88. Delneste Y, Lassalle P, Jeannin P, Joseph M, Tonnel AB, Gosset P. Histamine inducesIL-6 production by human endothelial cells. Clin Exp Immunol 1994; 98:344-349.
89. Jeannin P, Delneste Y, Gosset P, Molet S, Lassalle P, Hamid Q, Tsicopoulos A, TonnelAB. Histamine induces interleukin-8 secretion by endothelial cells. Blood 1994; 84:2229-2233.
90. Noah TL, Paradiso AM, Madden MC, McKinnon KP, Devlin RB. The response of ahuman bronchial epithelial cell line to histamine: Intracellular calcium changes andextracellular release of inflammatory mediators. Am J Respir Cell Mol Biol 1991; 5:484-492.
91. Irokawa T, Nagaki M, Shimura S, Sasaki T, Yamaya M, Yamauchi K, Shirato K. HMT regulates histamine-induced glycoconjugate secretion from human airways invitro. Respir Physiol 1997; 108:233 -240.
92. Tamaoki J, Nakata J, Takeyama K, Chiyotani A, Konno K. Histamine H2 receptor-mediated airway goblet cell secretion and its modulation by histamine-degrading enzymes. J Allergy Clin Immunol 1997; 99:233-238.
93. Benson MK, Graf PD. Bronchial reactivity: Interaction between vagal stimulation andinhaled histamine. J Appl Physiol 1977; 43:643-647.
94. Kikuchi Y, Okayama H, Okayama M, Sasaki H, Takishima T. Interaction betweenhistamine and vagal stimulation on tracheal smooth muscle in dogs. J Appl Physiol1984; 56:590-595.
95. Benson MK, Graf PD. Bronchial reactivity: Interaction between vagal stimulation andinhaled histamine. J Appl Physiol 1977; 43:643-647.
96. Casterline CL, Evans R, Ward GW, Jr. The effect of atropine and albuterol aerosolson the human bronchial response to histamine. J Allergy Clin Immunol 1976; 58:607-613.
97. Clark RA, Gallin JI, Kaplan AP. The selective eosinophil chemotactic activity ofhistamine. J Exp Med 1975; 142:1462-1476.
98. Clark RA, Sandler JA, Gallin JI, Kaplan AP. Histamine modulation of eosinophilmigration. J Immunol 1977; 118:137-145.
99. Cluzel M, Liu MC, Goldman DW, Undem BJ, Lichtenstein LM. Histamine acting ona histamine type 1 (H1) receptor increases beta-glucuronidase release from humanlung macrophages. Am J Respir Cell Mol Biol 1990; 3:603-609.
100. Bissonnette EY. Histamine inhibits tumor necrosis factor alpha release by mast cellsthrough H2 and H3 receptors. Am J Respir Cell Mol Biol 1996; 14:620-626.
101. Mashikian MV, Tarpy RE, Saukkonen JJ, Lim KG, Fine GD, Cruikshank WW, Center DM. Identification of IL-16 as the lymphocyte chemotactic activity in the bronchoal-veolar lavage fluid of histamine-challenged asthmatic patients. J Allergy Clin Immunol1998; 101:786-792.
102. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. JClin Invest 2001; 108:1865-1873.
103. Caron G, Delneste Y, Roelandts E, Duez C, Bonnefoy JY, Pestel J, Jeannin P. Histaminepolarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001; 167:3682-3686.
104. Osna N, Elliott K, Chaika O, Patterson E, Lewis RE, Khan MM. Histamine utilizesJAK-STAT pathway in regulating cytokine production. Int Immunopharmacol 2001;1:759-762.
105. Osna N, Elliott K, Khan MM. The effects of histamine on interferon gamma productionare dependent on the stimulatory signals. Int Immunopharmacol 2001; 1:135-145.
106. Elliott KA, Osna NA, Scofield MA, Khan MM. Regulation of IL-13 production byhistamine in cloned murine T helper type 2 cells. Int Immunopharmacol 2001; 1:1923-1937.
107. Barnes PJ. Histamine and serotonin. Pulm Pharmacol Ther 2001; 14:329-339.
108. Stevens RL, Austen KF. Proteoglycans of the mast cell. Kroc Found Ser 1981; 14:69-88.
109. Galli SJ. New insights into “the riddle of the mast cells”: Microenvironmental regulationof mast cell development and phenotypic heterogeneity. Lab Invest 1990; 62:5-33.
110. Enerback L. Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. Acta PatholMicrobiol Scand 1966; 66:289-302.
111. Enerback L. Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. Acta Pathol Microbiol Scand 1966; 66:303-312.
112. Beil WJ, Schulz M, Wefelmeyer U. Mast cell granule composition and tissue location—a close correlation. Histol Histopathol 2000; 15:937-946.
113. Uvnas B. Recent observations on mechanisms of storage and release of mast cellhistamine. Applicability to other biogenic amines. Agents Actions Suppl 1992; 36:23-33.
114. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C, Sharpe AH, Stevens RL. Heparin is essential for the storage of specific granule proteases in mastcells. Nature 1999; 400:769-772.
115. Forsberg E, Pejler G, Ringvall M, Lunderius C, Tomasini-Johansson B, Kusche-Gullb-erg M, Eriksson I, Ledin J, Hellman L, Kjellen L. Abnormal mast cells in mice deficientin a heparin-synthesizing enzyme. Nature 1999; 400:773-776.
116. Friend DS, Ghildyal N, Austen KF, Gurish MF, Matsumoto R, Stevens RL. Mast cellsthat reside at different locations in the jejunum of mice infected with Trichinella spiralisexhibit sequential changes in their granule ultrastructure and chymase phenotype. JCell Biol 1996; 135:279-290.
117. Friend DS, Ghildyal N, Gurish MF, Hunt J, Hu X, Austen KF, Stevens RL. Reversibleexpression of tryptases and chymases in the jejunal mast cells of mice infected withTrichinella spiralis. J Immunol 1998; 160:5537-5545.
118. Lever R, Page C. Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness. Pulm Pharmacol Ther 2001; 14:249-254.
119. Lassila R, Lindstedt K, Kovanen PT. Native macromolecular heparin proteoglycansexocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collageninteractions. Arterioscler Thromb Vasc Biol 1997; 17:3578-3587.
120. Tchougounova E, Pejler G. Regulation of extravascular coagulation and fibrinolysisby heparin-dependent mast cell chymase. FASEB J 2001; 15:2763-2765.
121. Tchougounova E, Forsberg E, Angelborg G, Kjellen L, Pejler G. Altered processingof fibronectin in mice lacking heparin a role for heparin-dependent mast cell chymasein fibronectin degradation. J Biol Chem 2001; 276:3772-3777.
122. Hallgren J, Karlson U, Poorafshar M, Hellman L, Pejler G. Mechanism for activation of mouse mast cell tryptase: Dependence on heparin and acidic pH for formationof active tetramers of mouse mast cell protease 6. Biochemistry 2000; 39:13068-13077.
123. Huang C, Morales G, Vagi A, Chanasyk K, Ferrazzi M, Burklow C, Qiu WT, FeyfantE, Sali A, Stevens RL. Formation of enzymatically active, homotypic, and heterotypictetramers of mouse mast cell tryptases. Dependence on a conserved Trp-rich domainon the surface. J Biol Chem 2000; 275:351-358.
124. Pereira PJ, Bergner A, Macedo-Ribeiro S, Huber R, Matschiner G, Fritz H, SommerhoffCP, Bode W. Human beta-tryptase is a ring-like tetramer with active sites facing acentral pore. Nature 1998; 392:306-311.
125. Lindstedt L, Lee M, Kovanen PT. Chymase bound to heparin is resistant to its naturalinhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.Atherosclerosis 2001; 155:87-97.
126. Bock JB, Scheller RH. SNARE proteins mediate lipid bilayer fusion. Proc Natl AcadSci USA 1999; 96:12227-12229.
127. Gonzalez LJ, Scheller RH. Regulation of membrane trafficking: Structural insightsfrom a Rab/effector complex. Cell 1999; 96:755-758.
128. Carr CM, Novick PJ. Membrane fusion. Changing partners. Nature 2000; 404:347-349.
129. Sutton RB, Fasshauer D, Jahn R, Brunger AT. Crystal structure of a SNARE complexinvolved in synaptic exocytosis at 2.4 A resolution. Nature 1998; 395:347-353.
130. Wu MN, Fergestad T, Lloyd TE, He Y, Broadie K, Bellen HJ. Syntaxin 1A interactswith multiple exocytic proteins to regulate neurotransmitter release in vivo. Neuron1999; 23:593-605.
131. Dulubova I, Sugita S, Hill S, Hosaka M, Fernandez I, Sudhof TC, Rizo J. A conformational switch in syntaxin during exocytosis: Role of munc18. EMBO J 1999; 18:4372-4382.
132. Jahn R. Sec1/Munc18 proteins: Mediators of membrane fusion moving to center stage.Neuron 2000; 27:201-204.
133. Sassa T, Harada S, Ogawa H, Rand JB, Maruyama IN, Hosono R. Regulation of theUNC-18-caenorhabditis elegans syntaxin complex by UNC-13. J Neurosci 1999; 19:4772-4777.
134. Betz A, Okamoto M, Benseler F, Brose N. Direct interaction of the rat unc-13 homologue Munc13-1 with the N terminus of syntaxin. J Biol Chem 1997; 272:2520-2526.
135. Nicholson KL, Munson M, Miller RB, Filip TJ, Fairman R, Hughson FM. Regulationof SNARE complex assembly by an N-terminal domain of the t-SNARE Sso1p. NatStruct Biol 1998; 5:793-802.
136. Knight DA, Lim S, Scaffidi AK, Roche N, Chung KF, Stewart GA, Thompson PJ.Protease-activated receptors in human airways: Upregulation of PAR-2 in respiratoryepithelium from patients with asthma. J Allergy Clin Immunol 2001; 108:797-803.
137. Schimmoller F, Simon I, Pfeffer SR. Rab GTPases, directors of vesicle docking. JBiol Chem 1998; 273:22161-22164.
138. Augustine GJ. How does calcium trigger neurotransmitter release? Curr Opin Neurobiol2001; 11:320-326.
139. Bai J, Wang P, Chapman ER. C2A activates a cryptic Ca(2 +)-triggered membranepenetration activity within the C2B domain of synaptotagmin I. Proc Natl Acad SciUSA 2002; 99:1665-1670.
140. Hu K, Carroll J, Fedorovich S, Rickman C, Sukhodub A, Davletov B. Vesicular restriction of synaptobrevin suggests a role for calcium in membrane fusion. Nature 2002;415:646-650.
141. Schulze KL, Broadie K, Perin MS, Bellen HJ. Genetic and electrophysiological studiesof Drosophila syntaxin-1A demonstrate its role in nonneuronal secretion and neurotransmission. Cell 1995; 80:311-320.
142. Wu MN, Littleton JT, Bhat MA, Prokop A, Bellen HJ. ROP, the Drosophila Sec1homolog, interacts with syntaxin and regulates neruotransmitter release in a dosage-dependent manner. EMBO J 1997; 17:127-139.
143. Washbourne P, Thompson PM, Carta M, Costa ET, Mathews JR, Lopez-Bendito G, Molnar Z, Becher MW, Valenzuela CF, Partridge LD, Wilson MC. Genetic ablationof the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat Neurosci2002; 5:19-26.
144. Schoch S, Deak F, Konigstorfer A, Mozhayeva M, Sara Y, Sudhof TC, Kavalali ET. SNARE function analyzed in synaptobrevin/VAMP knockout mice. Science 2001;294:1117-1122.
145. Verhage M, Mala AS, Plomp JJ, Brussaard AB, Heeroma JH, Vermeer H, ToonenRF, Hammer RE, van den Berg TK, Missler M, Geuze HJ, Sudhof TC. Synapticassembly of the brain in the absence of neurotransmitter secretion. Science 2000; 287:864-869.
146. Augustin I, Rosenmund C, Sudhof TC, Brose N. Munc13-1 is essential for fusioncompetence of glutamatergic synaptic vesicles. Nature 1999; 400:457-461.
147. Leenders AG, Lopes da Silva FH, Ghijsen WE, Verhage M. Rab3a is involved intransport of synaptic vesicles to the active zone in mouse brain nerve terminals. MolBiol Cell 2001; 12:3095-3102.
148. Voets T, Moser T, Lund PE, Chow RH, Geppert M, Sudhof TC, Neher E. Intracellularcalcium dependence of large dense-core vesicle exocytosis in the absence of synapto-tagmin I. Proc Natl Acad Sci USA 2001; 98:11680-11685.
149. Ravichandran V, Chawla A, Roche PA. Identification of a novel syntaxin- and synapto-brevin/VAMP-binding protein, SNAP-23, expressed in non-neuronal tissues. J BiolChem 1996; 271:13300-13303.
150. Steegmaier M, Yang B, Yoo JS, Huang B, Shen M, Yu S, Luo Y, Scheller RH. Threenovel proteins of the syntaxin/SNAP-25 family. J Biol Chem 1998; 273:34171-34179.
151. Guo Z, Turner C, Castle D. Relocation of the t-SNARE SNAP-23 from lamellipodia-like cell surface projections regulates compound exocytosis in mast cells. Cell 1998;94:537-548.
152. Paumet F, Le Mao J, Martin S, Galli T, David B, Blank U, Roa M. Soluble NSFattachment protein receptors (SNAREs) in RBL-2H3 mast cells: Functional role ofsyntaxin 4 in exocytosis and identification of a vesicle-associated membrane protein8-containing secretory compartment. J Immunol 2000; 164:5850-5857.
153. St Denis JF, Cabaniols JP, Cushman SW, Roche PA. SNAP-23 participates in SNAREcomplex assembly in rat adipose cells. Biochem J 1999; 338 (Pt 3):709-715.
154. Flaumenhaft R, Croce K, Chen E, Furie B, Furie BC. Proteins of the exocytotic corecomplex mediate platelet alpha-granule secretion. Roles of vesicle-associated membrane protein, snap-23, and syntaxin 4. J Biol Chem 1999; 274:2492-2501.
155. Vaidyanathan VV, Puri N, Roche PA. The last exon of SNAP-23 regulates granuleexocytosis from mast cells. J Biol Chem 2001; 276:25101-25106.
156. 2 +-triggered exocytosis of lysosomes inmast cells. J Exp Med 1999; 189:1649-1658.
157. 2+ sensor, synaptotagmin I. J Immunol 1998; 161:5120-5123.
158. Butz S, Fernandez-Chacon R, Schmitz F, Jahn R, Sudhof TC. The subcellular localizations of atypical synaptotagmins III and VI. J Biol Chem 1999; 274:18290-18296.
159. Sugita S, Shin OH, Han W, Lao Y, Sudhof TC. Synaptotagmins form a hierarchyof exocytotic Ca(2 +) sensors with distinct Ca(2 +) affinities. EMBO J 2002; 21:270-280.
160. Mizuta M, Kurose T, Miki T, Shoji-Kasai Y, Takahashi M, Seino S, Matsukura S.Localization and functional role of synaptotagmin III in insulin secretory vesicles inpancreatic beta-cells. Diabetes 1997; 46:2002-2006.
161. Brown H, Meister B, Deeney J, Corkey BE, Yang SN, Larsson O, Rhodes CJ, Seino S, Berggren PO, Fried G. Synaptotagmin III isoform is compartmentalized in pancreaticbeta-cells and has a functional role in exocytosis. Diabetes 2000; 49:383-391.
162. 2+-induced insulin secretion in pancreatic islet beta-cells. J BiolChem 2000; 275:36079-36085.
163. Von Poser C, Sudhof TC. Synaptotagmin 13: Structure and expression of a novelsynaptotagmin. Eur J Cell Biol 2001; 80:41-47.
164. 2-domain proteins that regulate membranetraffic. Neuron 1996; 17:379-388.
165. Sutton RB, Ernst JA, Brunger AT. Crystal structure of the cytosolic C2A-C2B domainsof synaptotagmin III. Implications for Ca(+ 2)-independent snare complex interaction.J Cell Biol 1999; 147:589-598.
166. 2+responses and secretion in individual RBL-2H3 mucosal mast cells. J Biol Chem 1997;272:31225-31229.
167. Kuchtey J, Fewtrell C. Protein kinase C activator PMA reduces the Ca(2 +) responseto antigen stimulation of adherent RBL-2H3 mucosal mast cells by inhibiting depletionof intracellular Ca(2 +) stores. J Cell Physiol 1999; 181:113-123.
168. Fischer von Mollard G, Sudhof TC, Jahn R. A small GTP-binding protein dissociatesfrom synaptic vesicles during exocytosis. Nature 1991; 349:79-81.
169. Tuvim MJ, Adachi R, Chocano JF, Moore RH, Lampert RM, Zera E, Romero E, KnollBJ, Dickey BF. Rab3D, a small GTPase, is localized on mast cell secretory granulesand translocates to the plasma membrane upon exocytosis. Am J Respir Cell Mol Biol1999; 20:79-89.
170. Roa M, Paumet F, Le Mao J, David B, Blank U. Involvement of the ras-like GTPaserab3d in RBL-2H3 mast cell exocytosis following stimulation via high affinity IgEreceptors. J Immunol 1997; 159:2815-2823.
171. Baldini G, Scherer PE, Lodish HF. Nonneuronal expression of rab3A: Induction duringadipogenesis and association with different intracellular membranes than rab3D. ProcNatl Acad Sci USA 1995; 92:4284-4288.
172. Adachi R, Nigam R, Tuvim MJ, DeMayo F, Dickey BF. Genomic organization, chromosomal localization, and expression of the murine RAB3D gene. Biochem BiophysRes Commun 2000; 273:877-883.
173. Masuda ES, Luo Y, Young C, Shen M, Rossi AB, Huang BC, Yu S, Bennett MK, Payan DG, Scheller RH. Rab37 is a novel mast cell specific GTPase localized tosecretory granules. FEBS Lett 2000; 470:61-64.
174. Pinxteren JA, O’Sullivan AJ, Larbi KY, Tatham PE, Gomperts BD. Thirty years ofstimulus-secretion coupling: From Ca(2 +) to GTP in the regulation of exocytosis.Biochimie 2000; 82:385-393.
175. Fernandez-Chacon R, De Toledo GA, Hammer RE, dhof TC. Analysis of SCAMP1function in secretory vesicle exocytosis by means of gene targeting in mice. J BiolChem 1999; 274:32551-32554.
176. Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): From physiology to pathology.Annu Rev Immunol 1999; 17:931-972.
177. Marom Z, Shelhamer J, Berger M, Frank M, Kaliner M. Anaphylatoxin C3a enhancesmucous glycoprotein release from human airways in vitro. J Exp Med 1985; 161:657-668.
178. Hilfiker S, Augustine GJ. Regulation of synaptic vesicle fusion by protein kinase C.J Physiol (Lond) 1999; 515:1.
179. DeVries KJ, Geijtenbeek A, Brian EC, de Graan PN, Ghijsen WE, Verhage M. Dynamics of munc18-1 phosphorylation/dephosphorylation in rat brain nerve terminals. EurJ Neurosci 2000; 12:385-390.
180. Rhee JS, Betz A, Pyott S, Relm K, Varoqueaux F, Augustin I, Hesse D, Sudhof TC, Takahashi M, Rosenmund C, Brose N. Beta phorbol ester- and diacylglycerol-inducedaugmentation of transmitter release is mediated by Munc13s and not by PKCs. Cell2002; 108:121-133.
181. Hilfiker S, Pieribone VA, Nordstedt C, Greengard P, Czernik AJ. Regulation of synap-totagmin I phosphorylation by multiple protein kinases. J Neurochem 1999; 73:921-932.
182. Pombo I, Martin-Verdeaux S, Iannascoll B, Le Mao J, Deriano L, Rivera J, Blank U.IgE receptor type I-dependent regulation of a Rab3D-associated kinase: A possible linkin the calcium-dependent assembly of SNARE complexes. J Biol Chem 2001; 276:42893-42900.